Brief: Eliem Therapeutics Says Current Cash And Marketable Securities To Fund Ops Till Late 2023

Climb Bio

07/03/2022 21:11

March 7 (Reuters) - Eliem Therapeutics Inc  ELYM.O :
    * ELIEM THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END
FINANCIAL
AND BUSINESS HIGHLIGHTS
    * ELIEM THERAPEUTICS INC - CURRENT CASH, CASH EQUIVALENTS
AND
MARKETABLE SECURITIES ARE EXPECTED TO FUND OPERATIONS THROUGH
LATE 2023

Source text for Eikon:  ID:nGNXCHcw6 
Further company coverage:  ELYM.O 

 ((Reuters.Briefs@thomsonreuters.com;))